{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:00:53Z","timestamp":1790103653947,"version":"4.0.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chongzuo Municipal Bureau of Science and Technology","award":["2022QN1223"],"award-info":[{"award-number":["2022QN1223"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Preeclampsia is a pregnancy-specific hypertensive disorder associated with systemic inflammation, endothelial dysfunction, and adverse maternal and fetal outcomes. The nuclear factor kappa B (NF-\u03baB) signaling pathway has been implicated in inflammatory activation, but its role in preeclampsia remains incompletely defined. This systematic review and meta-analysis aimed to evaluate the association between NF-\u03baB pathway activation and inflammatory responses in preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This meta-analysis reviewed 15 peer-reviewed articles focusing on the involvement of the NF-\u03baB pathway in preeclampsia. Quantitative assessments included changes in systolic and diastolic blood pressure and levels of key inflammatory mediators, including tumor necrosis factor-alpha (TNF-\u03b1), interleukin-1 beta, interleukin-6 (IL-6), and NF-\u03baB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Systolic and diastolic blood pressure were significantly elevated in patients with preeclampsia. TNF-\u03b1 and NF-\u03baB levels were also significantly increased, indicating enhanced inflammatory activation associated with the disease. In contrast, interleukin-1 beta and IL-6 levels did not differ significantly, although IL-6 showed a nonsignificant trend toward increased levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This meta-analysis suggests that NF-\u03baB activation, together with increased TNF-\u03b1 levels, may contribute to the inflammatory pathophysiology of preeclampsia. These findings support further investigation of NF-\u03baB-related pathways, including Sirtuin 1\u2013mediated regulation, as potential biomarkers and therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050552","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:02:18Z","timestamp":1789750938000},"page":"e50552","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The NF-\u03baB pathway in inflammatory responses in preeclampsia"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9762-6329","authenticated-orcid":false,"given":"Hui","family":"Zhang","sequence":"first","affiliation":[{"name":"Obstetrics Department, The People\u2019s Hospital of Chongzuo, Chongzuo, Guangxi Zhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Nong","sequence":"additional","affiliation":[{"name":"Obstetrics Department, The People\u2019s Hospital of Chongzuo, Chongzuo, Guangxi Zhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Huang","sequence":"additional","affiliation":[{"name":"Obstetrics Department, The People\u2019s Hospital of Chongzuo, Chongzuo, Guangxi Zhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyuan","family":"Wei","sequence":"additional","affiliation":[{"name":"Obstetrics Department, The People\u2019s Hospital of Chongzuo, Chongzuo, Guangxi Zhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihan","family":"Feng","sequence":"additional","affiliation":[{"name":"Obstetrics Department, The People\u2019s Hospital of Chongzuo, Chongzuo, Guangxi Zhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"12708","DOI":"10.1038\/s41598-021-92189-w","article-title":"Earlier onset of proteinuria or hypertension is a predictor of progression from gestational hypertension or gestational proteinuria to preeclampsia.","volume":"11","author":"Morikawa","year":"2021","journal-title":"Sci Rep"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/AOG.0b013e3181c14e3e","article-title":"Resolution of hypertension and proteinuria after preeclampsia.","volume":"114","author":"Berks","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R3-20260922","first-page":"7","article-title":"Risk factors and effective management of preeclampsia.","volume":"8","author":"English","year":"2015","journal-title":"Integr Blood Press Control"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bpa.2022.02.003","article-title":"Preeclampsia diagnosis and management.","volume":"36","author":"Overton","year":"2022","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"R5-20260922","first-page":"435","article-title":"Preeclampsia and late fetal growth restriction.","volume":"73","author":"Marasciulo","year":"2021","journal-title":"Minerva Obstet Gynecol"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tjog.2015.03.006","article-title":"Maternal and fetal risk factors affecting perinatal mortality in early and late fetal growth restriction.","volume":"54","author":"Demirci","year":"2015","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.3390\/jcm11206048","article-title":"Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease: a review.","volume":"11","author":"S\u0142awek-Szmyt","year":"2022","journal-title":"J Clin Med"},{"key":"R8-20260922","first-page":"197","article-title":"Immunology and genetic of preeclampsia.","volume":"13","author":"Serrano","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"R9-20260922","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2007.11.022","article-title":"Genetic and epigenetic factors contribute to the onset of preeclampsia.","volume":"282","author":"Chelbi","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"R10-20260922","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1152\/ajpregu.00020.2020","article-title":"Influences of environmental factors during preeclampsia.","volume":"319","author":"Dasinger","year":"2020","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00006254-199806000-00023","article-title":"Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies.","volume":"53","author":"Dekker","year":"1998","journal-title":"Obstet Gynecol Surv"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"S867","DOI":"10.1016\/j.ajog.2021.11.019","article-title":"Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia.","volume":"226","author":"Robillard","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20260922","first-page":"2317","article-title":"Diagnosis and management of preeclampsia.","volume":"70","author":"Wagner","year":"2004","journal-title":"Am Fam Physician"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"8238727","DOI":"10.1155\/2019\/8238727","article-title":"Cross\u2010talk between oxidative stress and inflammation in preeclampsia.","volume":"2019","author":"Ten\u00f3rio","year":"2019","journal-title":"Oxid Med Cell Longevity"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"3864941","DOI":"10.1155\/2020\/3864941","article-title":"The role of inflammation in the pathogenesis of preeclampsia.","volume":"2020","author":"Michalczyk","year":"2020","journal-title":"Mediators Inflamm"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3390\/cells10113055","article-title":"Vascular dysfunction in preeclampsia.","volume":"10","author":"Opichka","year":"2021","journal-title":"Cells"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"165961","DOI":"10.1016\/j.bbadis.2020.165961","article-title":"Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia.","volume":"1866","author":"Mar\u00edn","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R18-20260922","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00404-024-07393-6","article-title":"Advances in pathogenesis of preeclampsia.","volume":"309","author":"Yang","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"e30870","DOI":"10.1097\/MD.0000000000030870","article-title":"Cytokine-polymorphisms associated with preeclampsia: a review.","volume":"101","author":"Mora-Palazuelos","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"16210","DOI":"10.3390\/ijms242216210","article-title":"The role of sirtuin-1 (SIRT1) in the physiology and pathophysiology of the human placenta.","volume":"24","author":"W\u0105troba","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","article-title":"NF-\u03baB: blending metabolism, immunity, and inflammation.","volume":"43","author":"Capece","year":"2022","journal-title":"Trends Immunol"},{"key":"R22-20260922","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.","volume":"2019","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R23-20260922","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-\u03baB, inflammation, and metabolic disease.","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab"},{"key":"R24-20260922","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF\u2010\u03baB\u2010dependent transcription and cell survival by the SIRT1 deacetylase.","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J"},{"key":"R25-20260922","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/10641955.2011.642436","article-title":"Activation of NF-\u03baB in placentas of women with preeclampsia.","volume":"31","author":"Vaughan","year":"2012","journal-title":"Hypertens Pregnancy"},{"key":"R26-20260922","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nri2423","article-title":"New regulators of NF-\u03baB in inflammation.","volume":"8","author":"Ghosh","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R27-20260922","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-\u03baB: a key role in inflammatory diseases.","volume":"107","author":"Tak","year":"2001","journal-title":"J Clin Invest"},{"key":"R28-20260922","doi-asserted-by":"crossref","first-page":"831168","DOI":"10.3389\/fimmu.2022.831168","article-title":"Regulation of SIRT1 and its roles in inflammation.","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"R29-20260922","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.mad.2009.06.004","article-title":"Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1.","volume":"130","author":"Csiszar","year":"2009","journal-title":"Mech Ageing Dev"},{"key":"R30-20260922","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7150\/ijms.73012","article-title":"SIRT1: a novel protective molecule in pre-eclampsia.","volume":"19","author":"Liu","year":"2022","journal-title":"Int J Med Sci"},{"key":"R31-20260922","first-page":"705","article-title":"Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF\u2011\u03baB signaling pathway.","volume":"18","author":"Zhao","year":"2018","journal-title":"Mol Med Rep"},{"key":"R32-20260922","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3390\/ijms23052881","article-title":"The targeting of nuclear factor kappa B by drugs adopted for the prevention and treatment of preeclampsia.","volume":"23","author":"Sakowicz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R33-20260922","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.3390\/ijms21155574","article-title":"Canonical, non-canonical and atypical pathways of nuclear factor \u043ab activation in preeclampsia.","volume":"21","author":"Sakowicz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R35-20260922","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2174\/1389201019666180925120109","article-title":"Preeclampsia-current management and future approach.","volume":"19","author":"Dymara-Konopka","year":"2018","journal-title":"Curr Pharm Biotechnol"},{"issue":"5 Part 1","key":"R36-20260922","first-page":"757","article-title":"Obesity and preeclampsia: the potential role of inflammation.","volume":"98","author":"Wolf","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R37-20260922","doi-asserted-by":"crossref","first-page":"e8225","DOI":"10.1371\/journal.pone.0008225","article-title":"Cigarette smoking blocks the protective expression of Nrf2\/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation.","volume":"4","author":"Garbin","year":"2009","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:04:11Z","timestamp":1790100251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050552"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":36,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050552","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2025-12-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}